Inactivation of the Cullin (CUL)-RING E3 ligase by the NEDD8-activating enzyme inhibitor MLN4924 triggers protective autophagy in cancer cells
- PMID: 22874562
- PMCID: PMC3494597
- DOI: 10.4161/auto.21484
Inactivation of the Cullin (CUL)-RING E3 ligase by the NEDD8-activating enzyme inhibitor MLN4924 triggers protective autophagy in cancer cells
Abstract
The multiunit Cullin (CUL)-RING E3 ligase (CRL) controls diverse biological processes by targeting a mass of substrates for ubiquitination and degradation, whereas its dysfunction causes carcinogenesis. Post-translational neddylation of CUL, a process triggered by the NEDD8-activating enzyme E1 subunit 1 (NAE1), is required for CRL activation. Recently, MLN4924 was discovered via a high-throughput screen as a specific NAE1 inhibitor and first-in-class anticancer drug. By blocking CUL neddylation, MLN4924 inactivates CRL and causes the accumulation of CRL substrates that trigger cell cycle arrest, senescence and/or apoptosis to suppress the growth of cancer cells in vitro and in vivo. Recently, we found that MLN4924 also triggers protective autophagy in response to CRL inactivation. MLN4924-induced autophagy is attributed partially to the inhibition of mechanistic target of rapamycin (also known as mammalian target of rapamycin, MTOR) activity by the accumulation of the MTOR inhibitory protein DEPTOR, as well as reactive oxygen species (ROS)-induced stress. Moreover, the blockage of autophagy response enhances apoptosis in MLN4924-treated cells. Together, our findings not only reveal autophagy as a novel cellular response to CRL inactivation by MLN4924, but also provide a piece of proof-of-concept evidence for the combination of MLN4924 with autophagy inhibitors to enhance therapeutic efficacy.
Keywords: Cullin-RING E3 ligase; DEPTOR; MLN4924; MTOR; NEDD8-activating enzyme; SKP1-Cullin-F-box (SCF) E3 ligase; autophagy; neddylation.
Figures

Comment on
- Luo Z, Yu G, Lee HW, Li L, Wang L, Yang D, et al. The Nedd8-activating enzyme inhibitor MLN4924 induces autophagy and apoptosis to suppress liver cancer cell growth. Cancer Res. 2012;72:3360–71. doi: 10.1158/0008-5472.CAN-12-0388.
Similar articles
-
The Nedd8-activating enzyme inhibitor MLN4924 induces autophagy and apoptosis to suppress liver cancer cell growth.Cancer Res. 2012 Jul 1;72(13):3360-71. doi: 10.1158/0008-5472.CAN-12-0388. Epub 2012 May 4. Cancer Res. 2012. PMID: 22562464
-
Neddylation inhibitor MLN4924 suppresses growth and migration of human gastric cancer cells.Sci Rep. 2016 Apr 11;6:24218. doi: 10.1038/srep24218. Sci Rep. 2016. PMID: 27063292 Free PMC article.
-
Induction of p21-dependent senescence by an NAE inhibitor, MLN4924, as a mechanism of growth suppression.Neoplasia. 2011 Jun;13(6):561-9. doi: 10.1593/neo.11420. Neoplasia. 2011. PMID: 21677879 Free PMC article.
-
Targeting Neddylation pathways to inactivate cullin-RING ligases for anticancer therapy.Antioxid Redox Signal. 2014 Dec 10;21(17):2383-400. doi: 10.1089/ars.2013.5795. Epub 2014 Feb 20. Antioxid Redox Signal. 2014. PMID: 24410571 Free PMC article. Review.
-
Targeting Protein Neddylation for Cancer Therapy.Adv Exp Med Biol. 2020;1217:297-315. doi: 10.1007/978-981-15-1025-0_18. Adv Exp Med Biol. 2020. PMID: 31898235 Review.
Cited by
-
NEDD4-1 regulates migration and invasion of glioma cells through CNrasGEF ubiquitination in vitro.PLoS One. 2013 Dec 10;8(12):e82789. doi: 10.1371/journal.pone.0082789. eCollection 2013. PLoS One. 2013. PMID: 24340059 Free PMC article.
-
Protein neddylation and its role in health and diseases.Signal Transduct Target Ther. 2024 Apr 5;9(1):85. doi: 10.1038/s41392-024-01800-9. Signal Transduct Target Ther. 2024. PMID: 38575611 Free PMC article. Review.
-
Ubiquitination regulates autophagy in cancer: simple modifications, promising targets.J Transl Med. 2024 Oct 31;22(1):985. doi: 10.1186/s12967-024-05565-1. J Transl Med. 2024. PMID: 39482684 Free PMC article. Review.
-
Translational implications of endothelial cell dysfunction in association with chronic allograft rejection.Pediatr Nephrol. 2016 Jan;31(1):41-51. doi: 10.1007/s00467-015-3094-6. Epub 2015 Apr 24. Pediatr Nephrol. 2016. PMID: 25903640 Free PMC article. Review.
-
Insights into the post-translational modification and its emerging role in shaping the tumor microenvironment.Signal Transduct Target Ther. 2021 Dec 20;6(1):422. doi: 10.1038/s41392-021-00825-8. Signal Transduct Target Ther. 2021. PMID: 34924561 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous